US OptionsDetailed Quotes

LPTX241220C6000

Watchlist

0.40
0.000.00%

15min DelayClose Nov 22 16:00 ET

0.00High0.00Low

Leap Therapeutics Stock Discussion

OZ the Great

Nov 18 14:02

$Leap Therapeutics (LPTX.US)$ let's get back to $4+

Trytosaveabit

Sep 30 06:11

Update

$Leap Therapeutics (LPTX.US)$ Leap Therapeutics Announces Completion of Enrollment in Part B of the Defiance Study of Dkn-01 for the Treatment of Colorectal Cancer Patients

Trytosaveabit

Apr 19 16:00

Nice! And interesting to boot!

$Leap Therapeutics (LPTX.US)$ Leap Therapeutics 13G Filing Shows Gilead Sciences, Inc. Reported A 13.9% Stake In The Co As Of April 10, 2024

amiable Hedgehog_758

Apr 12 16:58

April 11
Leap Therapeutics announced it has entered into a securities purchase agreement with a select group of institutional investors to issue and sell an aggregate of 12.66M shares of its common stock at a price of $2.82 per share and pre-funded warrants to purchase 1.52M shares of common stock at a price of $2.819 per share of common stock issuable upon exercise of the pre-funded warrants, in a private placement. Leap anticipates the gross proceeds from the private placement will be approxi...

Trytosaveabit

Apr 11 11:50

$Leap Therapeutics (LPTX.US)$ Was just curious if any followers caught this? If so congrats and hope you secured profits 🥂💵

Jaguar8

Apr 11 07:32

$Leap Therapeutics (LPTX.US)$
NEWS
LEAP THERAPEUTICS ANNOUNCES $40 MILLION PRIVATE PLACEMENT
INTENDS TO USE NET PROCEEDS FROM FINANCING TO FUND CONTINUED DEVELOPMENT OF ITS LEAD MONOCLONAL ANTIBODY PROGRAM, DKN-01

Trytosaveabit

Apr 11 07:32

News

$Leap Therapeutics (LPTX.US)$ Leap Therapeutics Announces $40 Million Private Placement

Meltyy

Jan 24 03:25

Ph2 readouts in Q1 2024...

$Pfizer (PFE.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$Vera Therapeutics (VERA.US)$ Phase 2b
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$Akero Therapeutics (AKRO.US)$ Phase 2b
$Spruce Biosciences (SPRB.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Annexon (ANNX.US)$ Phase 2a
$Roivant Sciences (ROIV.US)$...

Meltyy

Jan 3 06:11

Upcoming Ph 2 readouts in Q1 2024…

$Cellectar BioSciences (CLRB.US)$ Phase 2
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2...

Trytosaveabit

Jan 2 06:05

Results next?

$Leap Therapeutics (LPTX.US)$ Leap Therapeutics Concludes Enrollment In The Randomized Controlled Part C Of Distinguish Study Of DKN-01 In Combination With BeiGene's Tislelizumab And Chemotherapy In Patients With Advanced Gastroesophageal Junction And Gastric Cancer
Benzinga· 1 min ago

No comment yet